{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:24:17Z","timestamp":1790853857494,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T00:00:00Z","timestamp":1195603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001225","type":"journal-article","created":{"date-parts":[[2007,11,20]],"date-time":"2007-11-20T23:11:00Z","timestamp":1195600260000},"page":"e1225","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS\/MPD-U and MPD"],"prefix":"10.1371","volume":"2","author":[{"given":"Lukasz P.","family":"Gondek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrian","family":"Szpurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/carcin\/bgl086","article-title":"Frequent occurrence of uniparental disomy in colorectal cancer.","volume":"28","author":"CL Andersen","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/0008-5472.375.65.2","article-title":"Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.","volume":"65(2)","author":"M Raghavan","year":"2005","journal-title":"Cancer Res."},{"key":"ref3","first-page":"1001","article-title":"Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat.Biotechnol.","volume":"18(9)","author":"K Lindblad-Toh","year":"2000"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V99.1.375","article-title":"Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia.","volume":"99(1)","author":"IM Morison","year":"2002","journal-title":"Blood"},{"key":"ref5","first-page":"65","article-title":"High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays. Cancer Genet.Cytogenet.","volume":"170(1)","author":"J Pei","year":"2006"},{"key":"ref6","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD and MDS-derived AML.","author":"L Gondek","year":"2007","journal-title":"Blood In press"},{"key":"ref7","article-title":"Prevalence and prognostic significance of allelic imbalance by single nucleotide polymorphism analysis in low risk myelodysplastic syndromes.","author":"A Mohamedali","year":"2007","journal-title":"Blood In press"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.leu.2404745","article-title":"Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS.","volume":"21(9)","author":"LP Gondek","year":"2007","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.","volume":"434(7037)","author":"C James","year":"2005","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365(9464)","author":"EJ Baxter","year":"2005","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders.","volume":"352(17)","author":"R Kralovics","year":"2005","journal-title":"N Engl J Med."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.","volume":"7(4)","author":"RL Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.","volume":"108(6)","author":"E Lippert","year":"2006","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.","volume":"30(3)","author":"R Kralovics","year":"2002","journal-title":"Exp.Hematol."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2404206","article-title":"JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.","volume":"20(6)","author":"DP Steensma","year":"2006","journal-title":"Leukemia"},{"key":"ref16","first-page":"1434","article-title":"The JAK2 V617F mutation in de novo acute myelogenous leukemias.","volume":"25(9)","author":"JW Lee","year":"2006","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.","volume":"106(6)","author":"AV Jones","year":"2005","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.","volume":"106(10)","author":"RL Levine","year":"2005","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood-2005-09-3644","article-title":"Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7.","volume":"107(3)","author":"S Frohling","year":"2006","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes.","volume":"106(4)","author":"DP Steensma","year":"2005","journal-title":"Blood"},{"key":"ref21","first-page":"45","article-title":"Myelodysplastic\/myeloproliferative disease.","author":"JW Vardiman","year":"2001"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation.","volume":"108(7)","author":"H Szpurka","year":"2006","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0889-8588(03)00087-X","article-title":"Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.","volume":"17(5)","author":"A Adeyinka","year":"2003","journal-title":"Hematol.Oncol.Clin.North Am."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.21868","article-title":"Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.","volume":"106","author":"D Dingli","year":"2006","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/cncr.21358","article-title":"Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.","volume":"104","author":"A Tefferi","year":"2005","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.2002.03763.x","article-title":"Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected.","volume":"119","author":"V Najfeld","year":"2002","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng1416","article-title":"Detection of large-scale variation in the human genome.","volume":"36(9)","author":"AJ Iafrate","year":"2004","journal-title":"Nat.Genet."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/518809","article-title":"Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.","volume":"81(1)","author":"G Yamamoto","year":"2007","journal-title":"Am.J Hum.Genet."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.","volume":"108(10)","author":"PJ Campbell","year":"2006","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","article-title":"Leukemic blasts in transformed JAK2-V617F positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.","volume":"110(1)","author":"A Theocharides","year":"2007","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.leukres.2004.07.014","article-title":"A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.","volume":"29(4)","author":"AI Cabello","year":"2005","journal-title":"Leuk.Res."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2006-01-029918","article-title":"Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias.","volume":"109(4)","author":"N Harir","year":"2007","journal-title":"Blood"},{"key":"ref33","first-page":"359","article-title":"Activated STAT5 proteins induce activation of the PI 3-kinase\/Akt and Ras\/MAPK pathways via the Gab2 scaffolding adapter.","volume":"390(Pt 1)","author":"R Nyga","year":"2006","journal-title":"Biochem.J."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/sj.leu.2404757","article-title":"Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.","volume":"21(8)","author":"R Tiu","year":"2007","journal-title":"Leukemia."},{"key":"ref35","first-page":"3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17(12)","author":"NL Harris","year":"1997","journal-title":"J.Clin.Oncol."},{"key":"ref36","article-title":"An international system for human cytogenetic nomenclature (2005) Karger: Basel.","author":"LG ISCN: Shaffer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1093\/nar\/29.17.e88","article-title":"An efficient procedure for genotyping single nucleotide polymorphisms.","volume":"29(17)","author":"S Ye","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9440(10)64076-X","article-title":"Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.","volume":"158(4)","author":"JM Nigro","year":"2001","journal-title":"Am.J.Pathol."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-05-0465","article-title":"A Robust Algorithm for Copy Number Detection Using High-Density Oligonucleotide Single Nucleotide Polymorphism Genotyping Arrays.","volume":"65(14)","author":"Y Nannya","year":"2005","journal-title":"Cancer Res."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T21:27:45Z","timestamp":1684099665000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001225"}},"subtitle":[],"editor":[{"given":"Mikhail","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,11,21]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001225","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,21]]}}}